TY  - GEN
AU  - Narula,Neeraj
AU  - Peerani,Farhad
AU  - Meserve,Joseph
AU  - Kochhar,Gursimran
AU  - Chaudrey,Khadija
AU  - Hartke,Justin
AU  - Chilukuri,Prianka
AU  - Koliani-Pace,Jenna
AU  - Winters,Adam
AU  - Katta,Leah
AU  - Shmidt,Eugenia
AU  - Hirten,Robert
AU  - Faleck,David
AU  - Parikh,Malav P
AU  - Whitehead,Diana
AU  - Boland,Brigid S
AU  - Singh,Siddharth
AU  - Sagi,Sashidhar Varma
AU  - Fischer,Monika
AU  - Chang,Shannon
AU  - Barocas,Morris
AU  - Luo,Michelle
AU  - Lasch,Karen
AU  - Bohm,Matthew
AU  - Lukin,Dana
AU  - Sultan,Keith
AU  - Swaminath,Arun
AU  - Hudesman,David
AU  - Gupta,Nitin
AU  - Shen,Bo
AU  - Kane,Sunanda
AU  - Loftus,Edward V
AU  - Siegel,Corey A
AU  - Sands,Bruce E
AU  - Colombel,Jean-Frederic
AU  - Sandborn,William J
AU  - Dulai,Parambir S
TI  - Vedolizumab for Ulcerative Colitis: Treatment Outcomes from the VICTORY Consortium
SN  - 1572-0241
PY  - 2019///0906
KW  - Adult
KW  - Antibodies, Monoclonal, Humanized
KW  - therapeutic use
KW  - Colectomy
KW  - statistics & numerical data
KW  - Colitis, Ulcerative
KW  - diagnosis
KW  - Colon
KW  - diagnostic imaging
KW  - Colonoscopy
KW  - Female
KW  - Follow-Up Studies
KW  - Gastrointestinal Agents
KW  - Glucocorticoids
KW  - Humans
KW  - Infections
KW  - epidemiology
KW  - Male
KW  - Middle Aged
KW  - Registries
KW  - Remission Induction
KW  - methods
KW  - Retrospective Studies
KW  - Severity of Illness Index
KW  - Treatment Outcome
KW  - Tumor Necrosis Factor-alpha
KW  - antagonists & inhibitors
N1  - Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1038/s41395-018-0162-0
ER  -